PANCREATIC CANCER CACHEXIA

Clinical trials for PANCREATIC CANCER CACHEXIA explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC CANCER CACHEXIA trials appear

Sign up with your email to follow new studies for PANCREATIC CANCER CACHEXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to reverse wasting in cancer patients

Symptom relief Recruiting now

This study tests a new drug called JMT203 in people with lung or pancreatic cancer who are losing weight and muscle (cancer cachexia). The goal is to see if the drug is safe and can help patients gain or maintain weight. About 307 adults will take part across two phases, starting…

Matched conditions: PANCREATIC CANCER CACHEXIA

Phase: PHASE1, PHASE2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Symptom relief

Last updated May 26, 2026 08:23 UTC

PANCREATIC CANCER CACHEXIA

Get alerted when new PANCREATIC CANCER CACHEXIA trials appear

New drug aims to reverse wasting in cancer patients